Home » FDA Approves NovaBone MacroFORM MIS Delivery System
FDA Approves NovaBone MacroFORM MIS Delivery System
The FDA has approved NovaBone Products’ MacroFORM MIS Delivery System for use in minimally invasive orthopedic procedures.
The system — developed for surgeons who require controlled and precise delivery of bone grafting material to not readily accessible surgical sites — facilitates absorption of bone marrow aspirate by mixing with bone marrow to yield a porous scaffold that facilitates bone growth.
Based in Jacksonville, Fla., NovaBone focuses on bioactive glass design and manufacturing. — Michael Cipriano
Upcoming Events
-
07May
-
14May
-
30May